Permax Articles
Eli Lilly Japan's 2006 sales up 7% to $700M
2 April 2007
Amarin Corp sees revenues plunge
5 April 2004
Valeant buys Amarin unit in $38M deal
23 February 2004
Permax competition slashes Amarin sales
18 August 2003
Amarin's revenues tumble in first quarter
9 June 2003
IVAX settles with Amarin over pergolide
19 May 2003
Amarin acquires USA rights to Permax
15 July 2002
Amarin sells Argentine transdermal patch unit
12 December 2001
Amarin revenues jump 191%
30 October 2001
Draxis gets Canadian approval for Permax
3 November 2000
China sees over-supply, low demand for drugs
16 March 2000
Hefty increase in 3rd qtr revenues at Elan
26 October 1999
Revenues Rise 63% At Ireland's Elan Corp In Third Quarter
27 October 1998
Strong Growth At Elan Corp, Net Income Up 51%
9 February 1998
Transitional First Quarter For Elan Corp
24 April 1997
Elan Corp Takes One-Time Charge At Nine Months
10 February 1997
FDA Approves Elan's Zanaflex For Spasticity
9 December 1996
Important Developments For US Biotechnology Cos
19 February 1996
P&U Files In USA For Parkinson's Drug
15 January 1996
US 3rd Qrt Results: Strong Gains For Pfizer, Lilly
23 October 1995
DEPRENYL ACQUIRES PARKINSON'S DRUG
28 February 1994
Showing 1-25 of 25 articles
- 1
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
